Even Breakthrough Patents Can Be Invalid, Sequenom Shows
The Federal Circuit's decision Friday that Sequenom Inc.'s patent for prenatal DNA tests is invalid for claiming a natural phenomenon makes clear that many medical and biotechnology patents are at risk...To view the full article, register now.
Already a subscriber? Click here to view full article